The Peptide Field. Epitalon: approval and research record.

Review date: 2026-07-23. Dataset version: 2026-09-11.1.

https://thepeptidefield.com/peptides/epitalon

Lookup: https://thepeptidefield.com/peptide-evidence-checker?peptide=epitalon#result

This is a dated summary, not a live FDA check or independent medical review. It does not recommend treatment or verify a product in hand.

Status: No FDA-approved epitalon drug product

Product limits: Similar names do not mean that products have the same evidence. Epitalon, epitalon acetate, and older pineal extracts such as epithalamin are not automatically interchangeable evidence objects.

Health results in people: Unclear. FDA found no studies establishing insomnia outcomes for the nominated epitalon substances and route.

Body changes in people: Limited. Melatonin and cell-line findings are indirect and do not establish patient benefit.

What research shows: Laboratory work has reported telomere-related effects in human cell lines. Telomeres are protective ends of chromosomes. FDA's current review found melatonin-related information but no clinical insomnia studies using the nominated substances by the proposed route.

Still unknown: Changes in cells grown in a laboratory do not establish slower aging, longer life, cancer prevention, or improved health in people. Evidence from epithalamin cannot be reassigned to epitalon.

Safety limits: A claim about longer life needs long-term results in people, not only laboratory mechanisms. This guide provides no injectable, sleep-treatment, or anti-aging regimen.

Sources used in this review (a source may support some statements, not all of them):

U.S. Food and Drug Administration. FDA briefing document for epitalon-related bulk drug substances. 2026. Accessed 2026-07-23. https://www.fda.gov/media/193345/download

PubMed · Biogerontology. Epitalon and telomere length in human cell lines. 2025. Accessed 2026-07-23. https://pubmed.ncbi.nlm.nih.gov/40908429/

U.S. Food and Drug Administration. July 2026 Pharmacy Compounding Advisory Committee meeting. 2026. Accessed 2026-07-23. https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026

Keep the limits, review date, and sources with this record. Check the current source for changes.